Location History:
- Yardley, PA (US) (2014 - 2017)
- Ekeren, BE (2019 - 2021)
Company Filing History:
9 out of 3,684 
9 out of 38 Years Active: 2014-2021
Title: Anish Suri: Innovator in Antibody Polypeptide Research
Introduction
Anish Suri is a prominent inventor based in Yardley, PA, known for his significant contributions to the field of antibody polypeptides. With a total of nine patents to his name, Suri has made remarkable strides in developing therapeutic solutions for diseases involving CD40L and CD40 activation.
Latest Patents
Suri's latest patents include innovative antibody polypeptides that antagonize CD40L. These polypeptides specifically bind to human CD40L without activating platelets, making them valuable in treating graft-related diseases and autoimmune disorders. Additionally, he has developed methods for treating immune diseases by administering antibody polypeptides that bind to a novel epitope of human CD40. These polypeptides also do not exhibit CD40 agonist activity, further enhancing their therapeutic potential.
Career Highlights
Throughout his career, Anish Suri has worked with notable companies such as Bristol-Myers Squibb Company and Domantis Limited. His experience in these organizations has contributed to his expertise in the field of immunology and antibody development.
Collaborations
Some of Suri's notable coworkers include Suzanne J. Suchard and Aaron Paul Yamniuk. Their collaborative efforts have likely played a role in advancing research and innovation in antibody therapies.
Conclusion
Anish Suri's work in antibody polypeptides showcases his dedication to improving treatments for complex diseases. His innovative patents and collaborations highlight his significant impact on the field of immunology.